Imaging in Inflammatory Carcinoma
Inflammatory carcinoma is a rare and aggressive form of primary epithelial cancer that includes 1–6 % of breast cancer and is associated to a poor prognosis given the high probability of micrometastases at diagnosis; about 20 % of patients have distant metastases at diagnosis , with a high incidence of recurrence, higher than those noninflammatory carcinoma.
Inflammatory breast cancer is diagnosed clinically by the rapid appearance of erythema and edema called “orange peel” involving at least one third of the skin around the breast. In this chapter, it discusses the various methods of imaging and its usefulness in the diagnosis of inflammatory breast cancer.
KeywordsPositron Emission Tomography Inflammatory Breast Cancer Internal Mammary Chain Positron Emission Mammography Granulomatous Mastitis
- 2.Edge SB, Byrd DR, Compton CC, et al. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.Google Scholar
- 5.Haagensen C. Diseases of the breast. 2ath ed. Philadelphia: Pasauder; 1971. p. 569–84.Google Scholar
- 9.Buzdar AU, et al. Effectiveness of mastectomy. Cancer. 1995;76:2286–2290.Google Scholar
- 11.Lee KW, Chung SY, Yang I, et al. Inflammatory breast cancer imaging findings. J Clin Imaging. 2005;29:22–5.Google Scholar
- 14.American College of Radiology (ACR). Illustrated breast imaging reporting and data system (BI-RADS). 3rd ed. Reston: American College of Radiology; 1998. p. 121–39.Google Scholar
- 21.Muna M, Siema B, Bakheet M, et al. 18-Fluorodeoxyglucose-positron emission tomography in inflammatory breast cancer. World J Surg. Société Internationale de Chirurgie. 2003;27(10):1099–104.Google Scholar